Combined-modality therapy for rectal cancer using irinotecan

被引：0
|
作者：
Minsky, BD
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[2] Cornell Univ, New York, NY USA
来源：
ONCOLOGY-NEW YORK | 2002年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Preoperative or postoperative pelvic radiation plus concurrent fluorouracil-based chemotherapy is standard adjuvant treatment for patients with T3 and/or N1/2 rectal cancer. Newer chemotherapeutic regimens have been developed for the treatment of patients with metastatic disease. Irinotecan (CPT-11, Camptosar)-based regimens have improved survival in patients with metastatic disease and are being actively investigated in combination with pelvic radiation therapy for patients with rectal cancer.
引用
收藏
页码：35 / 38
页数：4
相关论文
共 50 条
  • [31] Preclinical Advances in Combined-Modality Cancer Immunotherapy With Radiation Therapy
    Smith, Clayton A.
    Freeman, Michael L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01): : 11 - 14
  • [32] Combined-modality therapy in gastrointestinal cancers
    Thomas, Charles Richard, Jr.
    Bond, Theo
    COLORECTAL CANCER, 2013, 2 (01) : 27 - 30
  • [33] Combined-modality therapy for locoregionally advanced head and neck cancer
    Cmelak, AJ
    Murphy, BA
    Day, T
    ONCOLOGY-NEW YORK, 1999, 13 (10): : 83 - 91
  • [34] Radiation dose escalation in combined-modality therapy for esophageal cancer
    Willett, CG
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1151 - 1153
  • [35] Combined-modality therapy for esophageal cancer: Are we making progress?
    Gibson, MK
    Forastiere, AA
    CANCER JOURNAL, 2003, 9 (04): : 238 - 240
  • [36] Combined modality therapy for rectal and colon cancer
    Chawla, AK
    Kachnic, LA
    Clark, JW
    Willett, CG
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 101 - 112
  • [37] Circulating proteins in response to combined-modality therapy in locally advanced rectal cancer identified by antibody array screening
    Kalanxhi, Erta
    Hektoen, Helga Helseth
    Meltzer, Sebastian
    Dueland, Svein
    Redalen, Kathrine Roe
    Flatmark, Kjersti
    Ree, Anne Hansen
    CANCER RESEARCH, 2015, 75
  • [38] COMBINED-MODALITY THERAPY IN THE TREATMENT OF LOCAL-REGIONAL ESOPHAGEAL CANCER
    SALTZ, L
    KELSEN, D
    ANNALS OF ONCOLOGY, 1992, 3 (10) : 793 - 799
  • [39] Current and future strategies for combined-modality therapy in pancreatic cancer.
    Ko A.H.
    Tempero M.A.
    Current Oncology Reports, 2002, 4 (3) : 202 - 212
  • [40] Combined-modality therapy in pancreatic cancer: Current status and future directions
    McGinn, CJ
    Zalupski, MM
    CANCER JOURNAL, 2001, 7 (04): : 338 - 348
12345